User profiles for Jacqueline E. Shea
 | Jacqueline SheaCEO, Aeras Verified email at aeras.org Cited by 6765 |
Simultaneous identification of bacterial virulence genes by negative selection
An insertional mutagenesis system that uses transposons carrying unique DNA sequence
tags was developed for the isolation of bacterial virulence genes. The tags from a mixed …
tags was developed for the isolation of bacterial virulence genes. The tags from a mixed …
[HTML][HTML] Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial
Background BCG vaccination provides incomplete protection against tuberculosis in infants.
A new vaccine, modified Vaccinia Ankara virus expressing antigen 85A (MVA85A), was …
A new vaccine, modified Vaccinia Ankara virus expressing antigen 85A (MVA85A), was …
Identification of a virulence locus encoding a second type III secretion system in Salmonella typhimurium.
Mapping the insertion points of 16 signature-tagged transposon mutants on the Salmonella
typhimurium chromosome led to the identification of a 40-kb virulence gene cluster at minute …
typhimurium chromosome led to the identification of a 40-kb virulence gene cluster at minute …
Genes encoding putative effector proteins of the type III secretion system of Salmonella pathogenicity island 2 are required for bacterial virulence and proliferation in …
The type III secretion system of Salmonella pathogenicity island 2 (SPI‐2) is required for
systemic infection of this pathogen in mice. Cloning and sequencing of a central region of SPI‐2 …
systemic infection of this pathogen in mice. Cloning and sequencing of a central region of SPI‐2 …
[HTML][HTML] Safety and immunogenicity of INO-4800 DNA vaccine against SARS-CoV-2: A preliminary report of an open-label, Phase 1 clinical trial
…, J Lee, MJ Dallas, AS Brown, JE Shea… - …, 2021 - thelancet.com
Background A vaccine against SARS-CoV-2 is of high urgency. Here the safety and
immunogenicity induced by a DNA vaccine (INO-4800) targeting the full length spike antigen of …
immunogenicity induced by a DNA vaccine (INO-4800) targeting the full length spike antigen of …
Influence of the Salmonella typhimuriumPathogenicity Island 2 Type III Secretion System on Bacterial Growth in the Mouse
We have investigated the in vivo growth kinetics of aSalmonella typhimurium strain (P11D10)
carrying a mutation in ssaJ, a Salmonella pathogenicity island 2 (SPI2) gene encoding a …
carrying a mutation in ssaJ, a Salmonella pathogenicity island 2 (SPI2) gene encoding a …
Functional analysis of ssaJ and the ssaK/U operon, 13 genes encoding components of the type III secretion apparatus of Salmonella Pathogenicity Island 2
We have investigated the structure and transcriptional organization of 13 genes of Salmonella
Pathogenicity Island 2 (SPI2) that encode components of the second type III secretion …
Pathogenicity Island 2 (SPI2) that encode components of the second type III secretion …
Analysis of the boundaries of Salmonella pathogenicity island 2 and the corresponding chromosomal region of Escherichia coli K-12
We recently identified a pathogenicity island (SPI2) located at 30.7 centisomes on the
Salmonella typhimurium chromosome. SPI2 contains genes encoding a type III secretion system …
Salmonella typhimurium chromosome. SPI2 contains genes encoding a type III secretion system …
Safety and immunogenicity of INO-4800 DNA vaccine against SARS-CoV-2: a preliminary report of a randomized, blinded, placebo-controlled, Phase 2 clinical trial in …
…, R Spitz, RJ Juba, J Lee, M Dallas, AS Brown, JE Shea… - MedRxiv, 2021 - medrxiv.org
Background Vaccines against SARS-CoV-2 are still urgently needed as only 5% of the global
population has been vaccinated. Here we report the safety and immunogenicity of a DNA …
population has been vaccinated. Here we report the safety and immunogenicity of a DNA …
SARS-CoV-2 DNA vaccine INO-4800 induces durable immune responses capable of being boosted in a phase 1 open-label trial
…, M Dallas, A Shah Brown, JE Shea… - The Journal of …, 2022 - academic.oup.com
Background Additional severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
vaccines that are safe and effective as primary vaccines and boosters remain urgently needed …
vaccines that are safe and effective as primary vaccines and boosters remain urgently needed …
